Where Speed, Efficiency, & Accuracy Align
The AscencioDx® Molecular Detector
Highlights and Benefits:
Rapid Results: Delivers positive test results in as few as 20 minutes, thus expediting decision-making and enhancing patient care. No need to wait for an inconclusive antigen test or wait for a lab test result to come back.
Re-usable: This reusable device and its lightweight disposable components substantially decrease biowaste. This detector can be used > 4000 times.
Compact Size: Due to its size, this detector is portable and does not monopolize lab counter space.
Easy and Convenient: This CLIA-waived system is incredibly user-friendly and does not require extensive training, making it a suitable choice for all healthcare settings. Transitioning from your current or previous COVID-19 testing platform is easy with minimal cost. The perfect replacement for the Accula™ Dock and test kits.
Efficient Reporting: The platform simplifies test reporting and patient records with its dynamic QR code scanning feature, which allows for effortless logging of test results to our cloud-based Detector Portal. Capturing test results and sharing data just became that much easier.
Quality You Can Rely On: AscencioDx is FDA EUA authorized and we proudly manufacture in the United States to meet our strict quality standards.
Ideal Product Applications: Healthcare professionals, Physician office laboratories, Urgent Care providers, Mobile testing, etc.
Available Assays: COVID-19 today.
Future Products from Anavasi: New products from Anavasi are in development for multiplex respiratory panels and the detection of sexually transmitted infections.
“The system is very user-friendly and well-suited for urgent care clinics and occupational / workplace settings, as well as universities. The protocol is as simple as a rapid antigen test, yet the test has high specificity and sensitivity being a molecular assay.”
Dr. Heather Fehling, Ph.D., HCLD — Clinical Reference Laboratory
CSO Molecular Diagnostics & VP of Laboratory Sciences
The Technology:
The AscencioDx Molecular Detector is a rapid, highly accurate, easy-to-use medical device for conducting NAAT analysis of samples collected from patients in point-of-care (POC) settings with in vitro diagnostic supplies. It uses The AscencioDx COVID-19 Test. Specifically, this testing system uses reverse transcription loop-mediated isothermal amplification (RT-LAMP) for the qualitative detection of RNA from the COVID-19 virus in samples that are heated and illuminated (via fluorescence signals) in a reaction tube placed within the detector.
This patent pending design has a built-in redundancy where it detects 3 distinct regions of the SARS-CoV-2 viral genome making it robust against mutation. The detector runs an internal RNA control on every test sample to confirm amplification.
Test results are reported on the detector’s display screen generally in 30 minutes or less. Test results can be securely transmitted to the Anavasi Diagnostics cloud-based portal via a smartphone or barcode reader through a QR code generated on the detector screen. No patient data is entered or stored on the detector.
The Detector Portal:
Comprehensive digital platform supporting COVID-19 testing
Portal exclusively available with The AscencioDx Molecular Detector
No Bluetooth required or app to download
HIPAA compliant
Results securely transmitted from detector to the cloud-based portal via a QR Code
Automatically disseminates results to CDC, State and Local Health Agencies via CDC ReportStream
Intuitive and versatile dashboard with middleware connectivity capability to your existing LIMS and EMR systems
Eliminate manual processes of data management and reporting utilizing a secure portal dashboard
Comprehensive report generation and customizable “Passport” style report templates
With the click of a button, you can securely text and/or email result to your patient
Provide individual portal access to patients so they have a secure record of all their test results
The portal dashboard allows you to set up your organization, manage detectors, locations, operators, physicians and patient data seamlessly
